Radiation Biology

PV QA 1 - Poster Viewing Q&A 1

SU_43_2423 - Imipridone (ONC201) and Radiation Therapy combination shows promise in breast cancer treatment

Sunday, October 21
1:15 PM - 2:45 PM
Location: Innovation Hub, Exhibit Hall 3

Zeinab Abou Yehia, MD

Biography:
My name is Zeinab Abou Yehia; I graduated from the American University of Beirut in Lebanon. Recognizing the importance of research in the growth of the radiation oncology field, I enrolled in the Scholars in HeAlth Research Program (SHARP), a 12 credit program that was funded by the NIH to provide the required foundation for health scholars to pursue a career in clinical research. I then worked as a research fellow and a sub-investigator in two international oncology clinical trials at AUB. I then endorsed the opportunity to work as a post-doctoral research fellow clinical research fellow in the radiation oncology department at the University of Texas MD Anderson Cancer Center. I completed my intern year at the University of Oklahoma and I am now a PGYIII in radiation oncology at Rutgers. I envision myself in a future of academic medicine where I am able to combine my compassion to patients with my enthusiasm to make a difference on a larger, population-based scale through advancing clinical knowledge in research.

Presentation(s):

Send Email for Zeinab Abou Yehia


Assets

SU_43_2423 - Imipridone (ONC201) and Radiation Therapy combination shows promise in breast cancer treatment



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Imipridone (ONC201) and Radiation Therapy combination shows promise in breast cancer treatment